Last $30.49 USD
Change Today +0.14 / 0.46%
Volume 18.7M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 8:04 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Amy W. Schulman

AgeTotal Calculated CompensationThis person is connected to 115 board members in 2 different organizations across 4 different industries.

See Board Relationships
53--

Background*

Ms. Amy W. Schulman served as an Executive Vice President and General Counsel of Pfizer Inc. from December 2010 to December 31, 2013 and June 23, 2008 respectively and served as its Business Unit Lead of Consumer Healthcare. Ms. Schulman served as the President and General Manager of Nutrition at Pfizer Inc. since December 2010. She served as an Executive Vice President and Business Unit Lead of Pfizer Nutrition at Pfizer Inc. since December 2010, Corporate Secretary ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Trustee
2012-2013
Former Director
2014-Present
Director

Education*

Unknown/Other Education 1982
Wesleyan University
JD 1989
Yale Law School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $30.49 USD +0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
70.0K GBP
George W. Hebard III, M.B.AInterim Principal Executive Officer, Interim Chief Operating Officer and Secretary
Enzon Pharmaceuticals Inc.
$428.5K
Mark J. Ahn Ph.D.Chief Executive Officer, President and Director
Galena Biopharma, Inc.
$737.0K
Mark J. Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$377.5K
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.